SKP alleviates the ferroptosis in diabetic kidney disease through suppression of HIF-1α/HO-1 pathway based on network pharmacology analysis and experimental validation

Abstract Background Diabetic kidney disease (DKD) represents a microvascular complication of diabetes mellitus. Shenkang Pills (SKP), a traditional Chinese medicine formula, has been widely used in the treatment of DKD and has obvious antioxidant effect. Ferroptosis, a novel mode of cell death due t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yangtian Yan (Egilea), Ningning Yuan (Egilea), Yuchi Chen (Egilea), Yun Ma (Egilea), Ali Chen (Egilea), Fujing Wang (Egilea), Shihua Yan (Egilea), Zhuo'en He (Egilea), Jinyue He (Egilea), Chi Zhang (Egilea), Hao Wang (Egilea), Mingqing Wang (Egilea), Jianxin Diao (Egilea), Wei Xiao (Egilea)
Formatua: Liburua
Argitaratua: BMC, 2024-02-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri